Phase 1 driving simulation finds bedtime GlyphAllo for major depressive disorder shows no next-morning driving impairment, while advancing allopregnanolone-based oral treatment development.
|Slideshows|November 9, 2020
7 Mistakes in Treatment-Resistant Depression
Author(s)Chris Aiken, MD
Raise the dose, augment, or switch? A new study suggests we may need to give antidepressants more time to be effective.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Grants Breakthrough Device Designation to NET Recovery's Device for Stimulant Use Disorder
2
Positive Phase 2 Topline Results: Remlifanserin for the Treatment of Alzheimer Disease Psychosis
3
Using Psychotherapy for the Prevention of Relapse in Schizophrenia
4
Treating PTSD Among Veterans at Risk for Suicide
5